Ci Xu is a Senior Research Investigator at BeiGene, where they contribute to CMC analytical development. They previously held the role of Senior Scientist II in Analytical Development at WuXi Biologics, focusing on the process development of recombinant antibody therapeutics during the pre-clinical phase. In addition, Ci served as Group Lead II at WuXi Biologics and has extensive experience in analytical roles at Firmenich, where they discovered natural ingredients as salt substitutes in food. Ci earned a PhD in Chemical Biology from The University of Hong Kong and a Bachelor of Engineering in Applied Chemistry from East China University of Science and Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices